Faecalibacterium prausnitzii, a species from this genus, has been identified as a potential target for diabetes prevention or treatment strategies, such as prebiotics or probiotics, due to its role in producing butyrate, which enhances insulin homeostasis [63]. This evidence concerns the gene INS and diabetes mellitus.